Allergy-Immunology
Cardiology
Endocrinology
Gastroenterology
General Internal Medicine
Geriatric Medicine
Hematology / Oncology
Hepatology
Hospital Medicine
Immunotherapy
Infectious Diseases
Nephrology / Hypertension
Pulmonary & Critical Care
Rheumatology
Sports Medicine

Division of Cardiology

Bibliography 2001

2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 |

Publications

  1. Acanfora D, Gheorghiade M, Trojano L, Furgi G, Pasini E, Picone C, Papa A, Iannuzzi GL, Bonow RO, Rengo F. Relative lymphocyte count: a prognostic indicator of mortality in elderly patients with congestive heart failure. Am Heart J 2001;142:167-173.
  2. Adult Treatment Panel III [Stone NJ]. Executive Summary of The Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001;285:2486-2497. 
  3. Almeda F, Adler S, Rosenson RS.  Metastatic tumor infiltration of the pericardium masquerading as pericardial tamponade.  Am J Med 2001;111:504-505.
  4. Beohar N, Davidson CJ, Weigold G, Goodreau L, Benzuly KH, Bonow RO. Predictors of long-term outcomes following direct percutaneous coronary itervention for acute myocardial infarction. Am J Cardiol 2001;88:1103-1107.
  5. Beohar N, Chandwaney RH, Goodreau LM, Davidson CJ.  In-hospital and long-term   outcomes of patients with an acute myocardial infarction undergoing direct angioplasty during regular and after hours.  J Invasive Cardiol 2001;13:669-672.
  6. Bonow RO. Asymptomatic aortic regurgitation and mitral regurgitation. ACC Curr Journal Rev 2001;Mar/April:36-40.
  7. Bonow RO, Camici PG, DiCarli MF, Dilsizian V, Underwood SR, Vanoverschelde JLJ, Wijns W. Imaging in heart failure. J Nucl Cardiol 2001;8:296-305.
  8. Chandran KB, Mun JH, Chen JS, Nagaraj A, McPherson DD.  Effect on residual stress on femoral arterial stress-strain behaviour.  J Korean Soc Mech Engineering 2001;15:965-973.
  9. Chandwaney RH, Stathopoulos T, Sunew J, McPherson D, Davidson CJ.  Successful thrombolysis using the combination of tissue plasminogen activator and abciximab in an    adult with Kawasaki’s disease.  J Invasive Cardiol 2001; 13:651-653.
  10. Choe W, Neelagaru S, Passman R, Kadish A, Goldberger J.  Atrioventricular junction ablation performed via a patent foramen ovale. J Cardiovasc Electrophysiol 2001; 12:617.
  11. Choi JW, Goodreau LM, Davidson CJ.  Resource utilization and clinical outcomes of coronary stenting: a comparison if IVUS-guided and angiographic-guided stent implantation.  Am Heart J 2001;142:112-118.
  12. Choi KM, Kim RJ, Gubernikoff G, Vargas JD, Parker M, Judd RM. Transmural extent of acute myocardial infarction predicts long-term improvement in contractile function. Circulation 2001;104:1101-1107.
  13. Cotts WG and Johnson MR: The challenge of rejection and cardiac allograft vasculopathy. Heart Failure Rev  2001;6:227-240.
  14. Elliott MD, Kapoor A, Parker MA, Kaufman DB, Bonow RO, Gheorghiade M. Improvement in hypertension and decreased need for antihypertensive therapy after kidney/pancreas transplantation. Circulation 2001;104:563-569.
  15. Fintel DJ.  From bench to bedside: GP IIb-IIIa inhibitors.  Neurology 2001; 57(suppl 2):S12-S19.
  16. Fuchs S, Hendel RC, Baim DS, Moses JW, Oierre A, Laham RJ, Hung MK, Kuntz RE, Oietrusewicz M, Bonow RO, Leon MB, Kornowski R. Endocardial electromechanical mapping to assess myocardial viability and severity of ischemia:a comparative analysis with radionuclide perfusion imaging. Am J Cardiol 2001;87:874-880.
  17. Gheorghiade M, Bonow RO. An overview: beta-blocker therapy for mild-to-moderate chronic heart failure. Am J Med 2001:110 (suppl 7A):1S-7S.
  18. Gheorghiade M, Eichhorn EJ.  Practical aspects of using beta blocker adrenergic blockade in heart failure. Am J Med 2001; 110 (suppl 7A):68S-73S.
  19. Gilchrist IC, O’Shea JC, Kosoglou T, Jennings LK, Lorenz TJ, Kitt MM, Kleiman NS, Talley D, Aguirre F, Davidson CJ, Runyon J, Tcheng JE.  Pharmacodynamics and pharmacokinetics of higher-dose, double-bolus eptifibatide in percutaneous coronary intervention. Circulation 2001; 104:406-411.
  20. Goldberger JJ, Challapalli S, Tung R, Parker MA, Kadish A: Relationship of heart rate variability to parasympathetic effect. Circulation 2001;103:1977-1983.
  21. Goldberger JJ, Parker MA, Kadish AH: Over-AVID subgroup analysis[letter].  J Am Coll Cardiol 2001;38:1586.
  22. Grais IM, Miller AJ. The links between a golf fanatic’s arrhythmias. Cortlandt Forum 2001;14:32-35.
  23. Greenland P.  Beating high blood pressure with low sodium DASH.  New Engl J Med 2001;344:53-55.
  24. Greenland P, Smith SC, Grundy SM.  Improving coronary heart disease risk assessment in asymptomatic people:  role of traditional risk factors and noninvasive cardiovascular tests.  Circulation 2001;104:1863-1867.
  25. Hollenberg SM, Klein LW, Parrillo JE, Scherer M, Burns D, Tamburro P, Oberoi M, Johnson MR, Costanzo MR: Coronary endothelial dysfunction after heart transplantation predicts allograft vasculopathy and cardiac death. Circulation 2001;104:3091-3096.
  26. Holly TA. Book Review: Imaging in Cardiovascular Disease (Pohost GM, O’Rourke RA, Berman DS, Shah PM, eds.). J Nucl Cardiol 2001;8:713-714.
  27. Horvath KA, Belkind N, Wu I, Greene R, Doukas J, Lomasney JW, McPherson DD, Fullerton DA.  Functional comparison of transmyocardial revascularization by mechanical laser means.  Ann Thorac Surg 2001; 72:1997-2002.
  28. Kadish AH, Mayuga KA, Yablon Z, Schaechter A, Goldberger JJ, Passman RS, Palmer A, Zimmer M, Davidson CJ. Effectiveness of shielding for patinets during cardiac catheterization or electrophysiologic testing. Am J Cardiol 2001;88:1320-1323.
  29. Kadish AH, Buxton AE, Kennedy HL, Knight BP, Mason JW, Schuger CD, Tracy CM, Winters WL Jr, Boone AW, Elnicki M, Hirshfeld JW Jr, Lorell BH, Rodgers GP, Weitz HH. ACC/AHA Clinical Competence Statement on Electrocardiography and Ambulatory Electrocardiography: a report of the ACC/AHA/ACP–ASIM Task Force on Clinical Competence (ACC/AHA Committee to Develop a Clinical Competence Statement on Electrocardiography and Ambulatory Electrocardiography). J Am Coll Cardiol 2001;38:2091-2100 and Circulation 2001 104:3169-3178.
  30. Kao W, Pavlovic-Surjancev B. Management of acute heart failure exacerbation. Critical Care Clinics 2001;17:321-335.
  31. Kaufman DB, Leventhal JR, Elliot MD, Gallon LG, Parker MA, Gheorghiade M, Koffron AJ, Ferrario M, Abecassis MM, Fryer JP, Stuart FP. Pancreas transplantation at Northwestern University. Clin Transplant 2001; 239-246.
  32. Klocke FK, Simonetti OP, Judd RM, Kim RJ, Harris KR, Hedjbeli S, Fieno DS, Miller S, Chen V, Parker MA. Limits of detection of regional differences in vasodilated flow in viable myocardium by first-pass magnetic resonance perfusion imaging. Circulation 2001;104:2412-2416.
  33. Liu Y, Lai Y, Nagaraj A, Kane B, Hamilton A, Greene R, McPherson DD, Chandran KB.  Pulsatile flow simulation in arterial vascular segments with intravascular ultrasound images.  Med Engineering and Physics 2001; 23:583-595.
  34. McDermott MM, Ohlmiller SM, Liu K, Guralnik JM, Martin GJ, Pearce WH, Greenland P.  Gait alterations associated with walking impairment in peripheral arterial disease.  J Am Geriat Soc 2001;49:747-754.
  35. McDermott MM, Greenland P, Liu K, Guralnik JM, Criqui MH, Dolan NC, Chan C, Celic L, Pearce WH, Schneider JR, Sharma L, Clark E, Gibson D, Martin GJ.  Leg symptoms in peripheral arterial disease:  associated clinical characteristics and functional impairment.  JAMA 2001;286:1599-1606.
  36. McDermott MM, Kerwin DR, Liu K, Martin GJ, O’Brien E, Kaplan H, Greenland P.  Prevalence and significance of unrecognized lower extremity peripheral arterial disease in general medicine practice.  J Gen Int Med 2001;16:384-390.
  37. Miller AJ, Grais IM. An immortal porcine valve? Cortlandt Forum 2001;14:63.
  38. Miura K, Dyer AR, Greenland P, Daviglus ML, Hill M, Liu K, Garside DB, Stamler J.  Pulse pressure compared to other blood pressure indices in predicting 25-year cardiovascular and all-cause mortality:  The Chicago Heart Association Detection Project in Industry.  Hypertension 2001;38:232-237.
  39. Miura K, Daviglus ML, Greenland P, Stamler J.  Making prevention and management of hypertension work [commentary].  J Hum Hypertens 2001;15(1):1-3.
  40. Miura K, Daviglus ML, Dyer AR, Liu K, Garside DB, Stamler J, Greenland P.  Relationship of blood pressure to 25-year mortality from coronary heart disease, cardiovascular diseases, and all causes in young adult men:  the Chicago Heart Association Detection Project in Industry.  Arch Intern Med 2001;161:1501-1508.
  41. Mondelli JA, DiLuzio S, Nagaraj A, Kane BJ, Smulevitz B, Nagaraj AV, Greene R, McPherson DD, Rigolin V.  The validation of volumetric real time three dimensional echocardiography for the determination of left ventricular function.  J Am Soc Echo 2001;14:994-1000.
  42. Navas-Nacher EL, Colangelo L, Beam C, Greenland P.  Risk factors for coronary heart disease in men 18 to 39 years of age.  Ann Intern Med 2001;134:433-439.
  43. O'Connor CM, Gattis WA, Helkamp AS, Langer A, Larsen RL, Harrington RA, Berkowitz SD, O’Gara PT, Kopecky SL, Gheorghiade M, Daly R, Califf RM, Fuster V.  Comparison of two aspirin doses on ischemic stroke in post-myocardial infarction patients in the warfarin (Coumadin) Aspirin Reinfarction Study (CARS). Am J Cardiol 2001;88:541-546. 
  44. Passman R, Beshai J, Pavri B, Kimmel S.  Predicting post-coronary bypass atrial arrhythmias from the preoperative electrocardiogram.  Am Heart J 2001;142:806-810.
  45. Passman R, Kadish A: Polymorphic VT, long QT syndrome, and torsade-de-pointes.  Med Clin North Am 2001;85:321-341.
  46. Passman R, Kadish A: Polymorphic ventricular tachycardia.  Cardiac Electrophysiol Rev 2001;5:338-342.
  47. Pitt B, Williams G, Remme W, Desmond J, Martinez F, Lopez-Sendon J, Maggioni A, Zannad F, Neaton J, Roniker B, Hurley S, Burns D, Bittman R, Kleiman J. Gheorghiade M.  The EPHESUS Trial: eplerenone in patients with heart failure due to systolic dysfunction complicating acute myocardial infarction.  Eplerenone Post-AMI Heart Failure Efficacy and Survival Study. Cardiovasc Drugs Ther 2001;15:79-87.
  48. Racker DK.  Cardiac nomenclature. [Letter] Eur Heart J 2001; 22:521-22.
  49. Ricciardi MJ, Wu E, Davidson CJ, Choi KM, Klocke FJ, Bonow RO, Judd RM, Kim RJ. Visualization  of discrete microinfarction following percutaneous coronary intervention associated with mild creatine kinase-MB elevation. Circulation 2001;103:2780-2783.
  50. Rigolin VH, Vonesh MJ, Ng KH, Roth SI, Sehgal R, McPherson DD, Mehlman DJ. Structural evaluation ofporcine heart valve prostheses with radiofrequency ultrasound. Cardiovasc Path 2001;10:179-188.
  51. Rosenson RS, Tangney CC, Schaefer EJ.  Comparative study of HMG-CoA reductase inhibitors on fibrinogen.  Atherosclerosis 2001;155:463-466.
  52. Rosenson RS, Shott S, Lu L, Tangney CC.  Hypertriglyceridemia and other factors associated with plasma viscosity.  Am J Med 2001;110:488-492.
  53. Rosenson RS.  Managing the hypercholesterolemic patient: when statins are not enough.  JCOM 2001;8:47-54.
  54. Rosenson RS, Ali R, Katz R.  Elevated blood viscosity in patients with clinically inactive systemic lupus erythematosus.  Semin Arthritis Rheum 2001;31:52-57.
  55. Rosenson RS, Mosca LJ, Staffileno BA, Tangney CT.  Variability in fibrinogen measurements:  an obstacle to cardiovascular risk stratification. Atherosclerosis 2001;159:225-230.
  56. Sagawa T, Sagawa K, Kelly JE, Lokuta A, Tsai J, Kan E, Wasserstrom JA: Activation of purified cardiac ryanodine receptors by dihydropyridine agonists.  Amer J Physiol 2001;280:H1201-1207.
  57. Schilling RJ, Peters NS, Goldberger J, Kadish AH, Davies DW: Characterisation of the anatomy and conduction velocities of the human right atrial flutter circuit determined by noncontact mapping.  J Am Coll Cardiol 2001;38: 385-393.
  58. Shah M, O’Connor CM, Sopko G, Hasselblad V, Califf R, Stevenson LW for the ESCAPE Investigators [M Gheorghiade].  Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness (ESCAPE): Design and rationale. Am Heart J 2001;141:528-535. 
  59. Shah MR, Hasselblad V, Stinnett SS, Gheorghiade M, Svedberg K, Califf RM, O’Connor CM.  Hemodynamic profiles of advanced heart failure: association with clinical characteristics and long-term outcomes. J Cardiac Failure 2001;7:105-113.
  60. Shah MR, Hasselblad V, Gheorghiade M, Adams KF, Swedberg K, Califf RM, O’Connor CM.  The six minute walk: A guide to prognosis in patients with advanced heart failure. Am J Cardiol 2001; 88:987-993. 
  61. Shah MR, Stinnett SS, McNulty SE, Gheorghaide M, Zannad F, Uretsky B, Adams KF Jr., Califf RM, O’Connor CM.  Hemodynamics as surrogate end-points for survival in advanced heart failure: an analysis from FIRST. Am Heart J 2001;141:908-914. 
  62. Shaw LJ, O’Rourke RA, Brundage BH, Froelicher VF, Greenland P, Grundy SM, Hachomovitch R, Pohost GM, Weintraub WS, Winters WL, Jr.  Electron beam computed tomography for the diagnosis and prognosis of coronary artery disease.  Letter (response).  Circulation 2001;103:e87.
  63. Smith SC, Blair S, Bonow RO, Brass L, Cerqueira M, Dracup K, Fuster V, Gotto A, Grundy FS, Houston-Miller N, Jacobs A, Jones D, Krauss R, Mosca L, Ockene I, Pasternack R, Pearson T, Pfeffer M, Starke R, Taubert K. AHA/ACC Guidelines for secondary prevention in patients with coronary and other vascular disease: 2001 update. Circulation 2001;104:1577-1579 and J Am Coll Cardiol 2001;38:1581-1583.
  64. Staffileno BA, Braun LT, Flack JM, Rosenson RS.  The accumulative effects physical activity in hypertensive post-menopausal women.  J Cardiovascular Risk 2001;8:283-290.
  65. Stone NJ. Lowering low-density cholesterol with diet: the important role of functional foods as adjuncts. Coron Artery Dis 2001;12:547-552.
  66. Stone NJ. The optimal dietary strategy to manage risk associated with various dyslipidemias. Curr Cardiol Rep 2001;3:391-400.
  67. Strzelczyk TA, Quigg RJ, Pfeifer PB, Parker MA, Greenland P.  Accuracy of estimating exercise prescription intensity in patients with left ventricular systolic dysfunction.  J Cardiopulm Rehab 2001;21:158-163.
  68. Sunew, J, Chandwaney RH, Stein DW, Meyers S, Davidson CJ. Excimer laser facilitated percutaneous coronary intervention of a non-dilatable coronary stent. Cathet. Cardiovasc. Intervent 2001;53:513-517.
  69. Taneja T, Mahnert B, Passman R, Goldberger J, Kadish A.  Effects of gender and age on electrocardiographic and cardiac electrophysiologic properties in adults. Pacing Cardiovasc Electrophysiol 2001;4:16-21.
  70. Taneja T, Horvath G, Racker DK, GOldberger J, Kadish A. Excitable gap in canine fibrillating ventricular myocardium: effect of subacute and chronic myocardial infarction. J Cardiovasc Electrophysiol 2001; 12:708-715.
  71. Tangney CC, Mosca LJ, Otvos JD, Rosenson RS.  Oral 17-b estradiol and medroxyprogesterone acetate therapy in postmenopausal women increases HDL particle size.  Atherosclerosis 2001;155:425-430.
  72. Tcheng JE, Talley JD, O’Shea C, Gilchrist IC, Kleiman NS, Grines CL, Davidson CJ, Lincoff AM, Califf RM, Jennings LK, Kitt MM, Lorenz TJ.  Clinical Pharmacology of Higher Dose Eptifibatide in Percutaneous Coronary Intervention (The PRIDE Study).  Am J Cardiol 2001; 88:1097-1102.
  73. Van Horn L, Liu K, Gerber J, Garside D, Schiffer L, Gernhofer N, Greenland P.  Oats and soy in lipid-lowering diets for women with hypercholesterolemia:  Is there synergy?  J Am Diet Assoc 2001;101:1319-1325.
  74. Wright, K. B., F. J. Klocke, V. S. Deshpande, J. Zheng, K. Harris, R. Tang, J. P. Finn and D. Li.  Assessment of regional differences in myocardial blood flow using T2-weighted 3D BOLD imaging.  Magn Reson Med 2001;46:573-578.
  75. Wu E, Judd RM, Vargas J, Klocke FJ, Bonow RO, Kim RJ. Visualization of the presence, location and transmural extent of healed Q-wave and Non-Q-wave myocardial infarction. The Lancet 2001;357:21-28.

 Book Chapters

  1. Bonow RO. Hibernating myocardium: identification and management. In: Fedele F, ed. Cardiologia e Pneumologia. Rome: CEPI Srl. 2001:219-226.
  2. Choi JW, Davidson CJ.  Evaluation and Management of Cardiovascular Disease in Diabetic Patients.  Clinical Endocrinology Update 2001 Syllabus. The Endocrinology Society Press., Bethesda, MD. 2001;271-281.
  3. Davidson CJ, Bonow RO. Cardiac catheterization. In: Braunwald E, Zipes DP, Libby P, eds. Heart Disease: A Textbook of Cardiovascular Medicine. 6th Edition. Philadelphia: W.B. Saunders Company 2001:359-386.
  4. Dibs SR, Saxon LA: Arrhythmias and conduction disturbances associated with pregnancy. In: Podrid PJ, Kowey PK eds. Cardiac Arrhythmias: Mechanisms, Diagnosis, and Management. Philadelphia: Lippincott Williams & Wilkins, 2001:785-804.
  5. Ekery DL.  Cushing's Syndrome. In: Alpert JS, ed. The AHA Clinical Cardiac Consult. Philadelphia: Lippincott Williams & Wilkins 2001: 100-101.
  6. Ekery DL. Pheochromocytoma. In: Alpert JS, ed. The AHA Clinical Cardiac Consult. Philadelphia: Lippincott Williams & Wilkins 2001: 192-193.
  7. Gersh BJ, Braunwald E, Bonow RO. Chronic coronary artery disease. In: Braunwald E, Zipes DP, Libby P, eds. Heart Disease: A Textbook of Cardiovascular Medicine. 6th Edition. Philadelphia: W.B. Saunders Company 2001:1272-1352.
  8. Laskey WK, Babb J, Davidson CJ (eds).  Applications In Imaging Cardiac Interventions.  Amersham Health, Houston, TX. 2001.
  9. McCord H, Rosenson RS, eds. Win the Cholesterol War: 100 Real-Life Secrets to Trimming Points (and Pounds).  Emmaus, PA: Rodale Press, 2001.
  10. Mendelson MA. Gynecologic and obstetric issues in the adolescent with heart disease. In: Walsj CA, Doroshow RW, eds. Adolescent Cardiology. Philadelphia: Mosby 2001: 17-24.
  11. Nahlawi M, Holly TA. Preoperative consultation. In: Alpert JS, ed. Cardiology for the Primary Care Physician. 3rd edition. Philadelphia: Mosby 2001:17-24.
  12. Passman R, Kadish A.  Evaluation and treatment of polymorphic VT, long QT syndrome, and torsade-de-pointes. In Thakur, ed. Emergency Management of Cardiac Arrhythmias In Press
  13. Ricciardi MJ, Davidson CJ.  Complex Angioplasty. In: CathSAP II (Cardiac Catheterization and Interventional Cardiology Self-Assessment Program); American College of Cardiology; 2001.
  14. Ricciardi MJ, Beohar N, Davidson CJ. Cardiac catheterization and coronary angiography. In: Rosendorf C, ed. Essential Cardiology. Philadelphia: WB Saunders Company 2001.
  15. Rosenson RS. Patient information: Hyperlipidemia.  In: Rose B, ed. UpToDate. Wellesley, MA : BDR, Inc. 2001; Vol. 9.3.
  16. Rosenson RS. Fibrinolytic markers and cardiovascular risk. In: Rose B, ed. UpToDate. Wellesley, MA : BDR, Inc. 2001; Vol. 9.3.
  17. Tangney CC, Rosenson RS. Lipid lowering with diet or dietary supplements. In: Rose B, ed. UpToDate. Wellesley, MA : BDR, Inc. 2001; Vol. 9.3.
  18. Zampino M, Gheorghiade M. Results and clinical implications of recent trials in chronic heart failure.  Cardiologia e Pneumologia. In: Fedele F, ed. Cardiologia e Pneumologia. Rome: CEPI Srl. 2001:219-226

Abstracts

  1. Bello D, Farah FM, DiLuzio S, Shah D, O’Donahue J, Vargas JD, Parker M, Johnson MR, Cotts WG, Klocke FJ, Bonow RO, Judd M, Gheorghiade M. Prediction of contractile improvement in chronic heart failure patients treated with beta-blocker therapy. Circulation 2001:104:II-518.

  2. Benza RL, Felker GM, Zabel KM, Kao W, Hilkert RJ, Pearce D, Borzak S, Leimberger JD, Gheorghiade M.  Arrhythmias in heart failure exacerbations: the OPTIME-CHF Study. Circulation 2001:104:II-525.

  3. Benza RL, Felker GM, Zabel KM, Kao W, Hilkert RJ, Pearce D, Borzak S, Leimberger JD, O’Connor CM, Califf RM, Gheorghiade M.  Arrhythmias in heart failure exacerbations: the OPTIME-CHF Study. J Cardiac Failure 2001;7:58.  

  4. Beohar N, Davidson CJ, Shah A, Wang N, Decker R, Klocke FJ. Inhibition of balloon injury mediated apoptosis with local delivery of a caspase inhibitor. J Am Coll Cardiol 2001;37:44A.

  5. Beohar, N., J. D. Flaherty, L. A. MacDonald, F. J. Klocke and C. J. Davidson.  Antirestenotic effects of inhibition of balloon injury mediated apoptosis with local delivery of a caspase inhibitor.  Circulation 2001;104:II-544.

  6. Bromet DS, Holly TA, Satran A, Mieres JH, Frey MJ, Elliott MD, Hendel RC. Impact of adjunctive adenosine infusion during exercise myocardial perfusion imaging: preliminary results of the Both Exercise and Adenosine Stress Test (BEAST) Trial. Circulation 2001;104:II-612.

  7. Choe W, Rankovic V, Passman R, Goldberger J, Kadish A.  Atrial pacing site alters atrial activation times: a comparison of 5 pacing locations. Pacing Cardiovasc Electrophysiol 2001;24:645.

  8. Choi KM, Kim RJ, Gubernikoff G, Taylor D, Vargas JD, Parker M, Judd RM. Early assessment of myocardial salvage in patients after acute infarction by contrast enhanced MRI. Circulation 2001;104:II-535.

  9. Choi KM, Judd RM, Kim H, Wu E, Parker MA, Kim RJ. Detection of unrecognized myocardial infarction by contrast MRI in patients referred for coronary angiography. Circulation 2001;104:II-638.

  10. Choudhury L, Parker MA, Freher MA, Holly TA. Gender differences in the response to adenosine during myocardial perfusion imaging. J Nucl Cardiol 2001; 8:S3.

  11. Choudhury L, Mahroldt H, Wagner A, Elliott MD, Choi KM, Vargas JM, Bonow RO, Judd RM, Kim RJ. Myocardial scarring in minimally symptomatic patients with hypertrophic cardiomyopathy. Circulation 2001;104:II-757.

  12. De Marco T, Foster E, Schafer J, Chatterjee K, Dibs S, Saxon LA: Effect of chronic cardiac resynchronization on left ventricular remodeling and neurohormonal activation (abstract). J Am Coll Cardiol 2001; 37: 118A-119A.

  13. DilLuzio S, Shah DJ, Bello D, Johnson MR, Cotts WG, Bonow RO, Colangelo L,  Gheorghiade M, Rigolin VH. Patients with non-ischemic and ischemic cardiomyopathy demonstrate different patterns of improvement in echo score index after initiation of carvedilol. J Am Soc Echocardiogr 2001;14:457A. 

  14. Felker MC, Benza RL, Berger L, Teague SM, Leimberger JD, Lucas KD, Cuffe MS, Gheorghiade M, O’Connor CM.  Heart failure etiology and response to intravenous milrinone in decompensated heart failure: the OPTIME-CHF Study. Circulation 2001:104:II-421.

  15. Felker GM, Leimberger JD, Cuffe MS, Gheorghiade M.  The combination of digoxin and milrinone therapy is not associated with an increased risk of adverse outcomes in patients hospitalized for heart failure: results from the OPTIME-CHF Study. Circulation 2001:104:II-571.

  16. Felker FM, Leimberger JD, Califf RM, Cuffe MS, Gheorghiade M, O’Connor CM.  A predictive model for the risk of death or rehospitalization after admission for decompensated heart failure: results from the OPTIME-CHF Study. Circulation 2001:104:II-689.

  17. Freher M, Passman R, Goldberger J, Neelagaru S, Dibs S, Kadish A.  Accuracy of the medtronic mode switching algorithm for the detection of atrial tachycarrhythmias. Pacing Cardiovasc Electrophysiol 2001;24:592.

  18. Gattis WA, Chu AA, Chandler AB, Zabel KM, Felker GM, Leimberger JD, Wilensky M, Benza RL, Cuffe RM, O’Connor CM, Gheorghiade M.  Beta-blocker therapy in patients hospitalized for heart failure:clinical outcomes from the OPTIME-CHF Trial. J Cardiac Failure 2001;7:59.

  19. Gheorghiade M, Orlandi C, Gottlieb S, Corder C, Udelson J, Ouyang J, Konstam MA. Vasopression V2 receptor blockade versus fluid restriction in the treatment of hyponatremia: results from a multicenter randomized controlled trial. Circulation 2001:104:II-438.

  20. Hamilton A, Jain P, Rabbat M, Belkind N, Nagaraj A, Klegerman M, McPherson DD.  Targeted echogenic liposomes enhance the intravascular ultrasound image of fibrin in vitro under physiological flow conditions.  J Am Soc Echo 2001;14:436.

  21. Hamilton A, Huang SL, Nagaraj A, McPherson DD, Tiukinhoy SD, Klegerman M, MacDonald R.  Acoustic liposomes for targeted contrast enhancement: the effect of component lipids on echogenicity and stability.  J Am Soc Echo 2001;14:440.

  22. Hamilton AJ, Jain P, Huang SL, Rabbat M, Belkind N, Nagaraj A, MacDonald RC, Klegerman M, McPherson DD.  Quantitation and characterization of targeted echogenic liposome enhancement under physiologic flow.  J Invest Med 2001;49 286A.

  23. Hasan SA, Shah DJ, Ekery DL, Wen AE, Hamilton AJ, Fullerton DA, Bonow RO, Rigolin VH.  Changes in left ventricular size and hemodynamics are seen early after mitral valve repair in patients with mitral regurgitation and normal systolic function. J Am Coll Cardiol 2001;37:485A.

  24. Horvath KA, Lu CJ, Vargas JD, Kim RJ, Judd RM. Myocardial functiona recovery after FGF2 gene therapy as assessed by echocardiography and MRI. Circulation 2001;104:II-361.

  25. Huang SL, Hamilton AJ, Tiukinhoy SD, McPherson DD, MacDonald RC.  Stability of acoustic anionic lipid dispersions in serum.  J Invest Med 2001;49:286A.

  26. Huang SL, Tiukinhoy SD, McPherson DD, MacDonald RC.  Gene transfer to vascular endothelial cells: improved efficiency with receptor-targeted cationic lipoplexes in the presence of serum.  Mol Therapy 2001;3:S198.

  27. Irwin TL, Shah DJ, Smulevitz B, Nagaraj A, McPherson DD, Rigolin VH, Dove EL.  A novel automatic technique to identify left ventricular epicardium using transthoracic three-dimensional echo.  J Invest Med 2001; 49: 287A.  Circulation 2001;104:652.

  28. Irwin TL, VanderLeest R, Shah DJ, Smulevitz B, Nagaraj A, McPherson DD, Dove EL, Rigolin VH.  A novel automatic technique to calculate left ventricular volumes throughout the cardiac cycle using transthoracic three-dimensional echo.  J Invest Med 2001;49:287A.

  29. Kannankeril P, Goldberger J:  Electrophysiologic changes during exercise and recovery. Pacing Clin Electrophysiol 2001;24:II-629.

  30. Kannankeril PJ, Goldberger JJ: Parasympathetic effects on cardiac electrophysiology during exercise and recovery.  Circulation 2001;104:II-331.

  31. Klegerman ME, Huang S, Tiukinhoy S, MacDonald R, McPherson DD.  A quantitative immunoblot assay for measurement of liposome-coupled antibodies (AB). Proceedings Am Assoc Pharm Sciences 2001:86.

  32. Klocke FJ, Simonetti OP, Judd RM, Kim RJ., Miller S, Harris KR, Hedjbeli S, Fieno DS. Detection of regional reductions in coronary flow reserve using first-pass magnetic resonance imaging. J Am Coll Cardiol 2001;37:400A. 

  33. Marholdt H, Wagner A, Choi KM, Vargas JM, Kim RJ, Judd RM. Contrast MRI detects subendocardial infarcts in regions of normal wall motion. Circulation 2001;104:II-341.

  34. Mayuga K, Taneja T, Goldberger JJ, Kadish A:  Autonomic and non-autonomic components of “early repolarization”. Circulation 2001;104:II-691.

  35. McDermott MM, Hahn E, Cella D, Hanley K, Odom L, Ockene J, Hirsch A, Pearce W, Lipsky M, Criqui M, Greenland P. Disparities in health care for peripheral arterial patients: a national physician survey. J Gen Intern Med 2001;16(Suppl 1):208.

  36. Mutharason RK, Nagaraj A, Hamilton AJ, McPherson DD, Bharati S.  A method of accurate three-dimensional reconstruction of the atrioventricular conduction system.  J Am Coll Cardiol 2001:16:103A.

  37. Nahlawi M, Waligora M, Spies SM, Bonow RO, Kadish AH, Goldberger J. Effect of long- versus short-term ventricular pacing on left ventricular function. J Am Coll Cardiol 2001;37:128A.

  38. Nahlawi M, Waligora M, Spies, SM, Bonow RO, Kadish AH, Goldberger JJ: Recovery of left ventricular function following long-term ventricular pacing. Circulation 2001;104:II-756.

  39. Nishio M, Wasserstrom JA:  Inotropic and toxic effects of ouabain in cat ventricular myocytes in Na+- and K+-free conditions.  Biophys J 2001;80:599a.

  40. O’Connor CM, Gattis WA, Adams KF, Shah MR, Kobrin I, Mollod M, Cannon JD, Chandler AB, Gheorghiade M. A multicenter, randomized, double-blind, placebo-controlled trial to assess the efficacy and safety of tezosentan in patients with acute decompensated heart failure and acute coronary syndrome (RITZ-4). Circulation 2001:104:II-762.

  41. Passman R, Beshai J, Parker M, Pavri B, Kimmel S.  A prediction rule for post-CABG atrial fibrillation. Pacing Cardiovasc Electrophysiol 2001;24: 652.

  42. Rajamannan NM, Subramanian M, Sebo T, Niekrasz M, Stone NJ, Bonow RO, Spelsberg T. Atorvastatin inhibits hypercholesterolemic cellular proliferation and bone matrix productioin in the aortic valve. Circulation 2001;104:213.

  43. Regenfus M, Marholdt H, Wagner A, Ricciardi MJ, Choi KM, Parker MA, Klocke FJ, Judd RM, Kim RJ. Visualization of myocardial damage following successful coronary artery bypass surgery. Circulation 2001;104:II-637. 

  44. Ricciardi MJ, Davidson CJ, Knox K, Bennet CL. Active pharmacovigilance effort compared to the FDA’s Medwatch drug surveillance program for the detection of Ticlopidine- and Clopidogrel- associated thrombotic thrombocytopenic purpura. J Am Coll  Cardiol 2001;37:506A.

  45. Rosenson RS.  State of the art:  oxidative stress and inflammation:  new targets for statin therapy.  Jpn Circulation J  2001;65(Suppl. I-A):94.

  46. Rosenson RS, Tangney CC, Gordon B, Levine D, Parker T.  Elevated soluble tumor necrosis factor-a receptor levels in subjects with small LDL may contribute to the proinflammatory profile.  Jpn J Cardiovasc Dis Prev.  2001;36(Suppl):70.

  47. Rosenson RS, Tangney CC, Gordon B, Levine D, Parker T.  Pravastatin therapy reduces oxidative stress:  an important determinant of systemic inflammation.  Eur Heart J  2001;22(Suppl):646.

  48. Rosenson RS, Tangney CC, Gordon B, Levine D, Parker T.  Elevated soluble tumor necrosis factor-a receptor levels in subjects with small LDL may contribute to the proinflammatory profile. Circulation  2001;104:II-837.

  49. Russo RJ, Attubato MJ, Davidson CJ, DeFranco AC, Hermiller JB, Laffaldano RA, Ling FS, Lucisano JE, Silva PD, Smith GJ, Wong SC. Intravascular ultrasound-directed stent placement in the left anterior descending coronary artery: Observations form AVID. J Am Coll Cardiol 2001;37:20A.

  50. Russo RJ, Attubato MJ, Davidson CJ, DeFranco AC, Fitzgerald PJ, Hermiller JB, Laffaldano RA, Ling FS, Lucisano JE, Silva PD, Smith GJ, Wong SC. Assessment of coronary stent expansion: angiographic diameter versus intravascular ultrasound cross-sectional area: observations from AVID. J Am Coll Cardiol 2001:37:27A.

  51. Russo RJ, Lucsiano JE, Silva PD, Attubato MJ, Davidson CJ, Defranco AC, Hermiller JB, Iaffaldano RA, Ling FS, Smith GJ. Intravascular ultrasound-directed stent placement in small coronary arteries: observations from AVID. Circulation 2001;104:II-743.

  52. Shah DJ, DiLuzio S, Bello D, Johnson MR, Cotts WG, O’Donohue JA, Bonow RO, Gheorghiade M, Rigolin VH. Dobutamine stress echocardiography demonstrates strong negative predictive accuracy on follow-up contractile function after beta blocker therapy in heart failure patients. J Am Soc Echocardiogr 2001;14:441A.

  53. Shah DJ, DiLuzio S, Ambardekar AV, Smulevitz B, Smith GL, Nagaraj A, Hamilton AJ, McPherson DD, Rigolin VH.  The evaluation of valvular regurgitation severity using digital acquisition of echocardiographic images.  J Invest Med 2001;49:287A.

  54. Shah DJ, DiLuzio S, Bello D, Johnson MR, Cotts WG, Bonow RO, Gheorghiade M, Rigolin VH. The differences in response to beta blocker therapy between patients with dilated and ischemic cardiomyopathy are related to the presence of contractile reserve on dobutamine echocardiography. Circulation 2001;104:518.

  55. Shah DJ, DiLuzio S, Bello D, Johnson MR, Cotts WG, Bonow RO, Gheorghiade M, Rigolin VH. Dobutamine echocardiography for predicting functional recovery of myocardium in heart failure patients treated with beta blocker therapy.  Circulation 2001; 104:518.

  56. Taneja T, Kadish A, Goldberger J: Does atrio-ventricular synchrony during ventricular tachycardia improve blood pressure response?  J Am Coll Cardiol 2001;37:119A.

  57. Taneja T, Horvath G, Goldberger J, Kadish A:  Correlation of excitable gap in canine VF to local electrophysiologic properties. Pacing Clin Electrophysiol 2001;24:II-647.

  58. Taneja T, Goldberger J, Passman R, Kadish A.  Ventricular fibrillation characteristics of induced and spontaneous ventricular fibrillation.  Circulation 2001;104: II-382.

  59. Tiukinhoy SD, Huang S, Khan AA, MacDonald R, McPherson DD.  Novel acoustic drug-encapsulated lipsomes for site-specific delivery. J Am Coll Cardiol 2001;16:256A.  

  60. Tiukinhoy SD, Huang S, Klegerman ME, Khan AA, MacDonald RC, McPherson DD.  Antibody-conjugation to novel acoustic drug-encapsulated liposomes for directed drug delivery. J Am Soc Echo 2001;14:469.  

  61. Tiukinhoy SD, Khan A, Huang SL, MacDonald RC, McPherson DD.  Inhibition of chlamydial growth in endothelial cells using novel acoustic azithromycin-loaded liposomes.  J Invest Med 2001;49:285A.

  62. Wagner A, Mahrholdt H, Holly T, Elliott M, Choi K, Kim RJ, Judd RM. MRI detects subendocardial infarcts which are missed by SPECT. Circulation 2001;104:II-534.

  63. Wasserstrom JA, Kelly JE, Wasserstrom LA:  Activation of purified human and canine cardiac ryanodine receptors by FPL 64176. Biophys J 2001;80:188a.

  64. Williams RE, Hughes S, Weaver F, Gheorghiade M. Impact of a congestive heart failure home care protocol: results of a multi-centered prospective randomized clinical trial. J Cardiac Failure 2001;7:86.  

  65. Zampino M, Orlandi C, Gheorghaide M. Vasopressin II receptor blockade in patients with congestive heart failure. J Cardiac Failure 2001;7:31.